At the same time, we observed that the high expression level of SETBP1 reduced the disease free survival in patients of BLCA and low expression level of SETBP1 reduced the disease free survival in patients of KIRC, OV and PAAD. The gene discussed is SETBP1; the disease is pancreatic adenocarcinoma.